Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
WASHINGTON (Reuters) - A study of Genzyme Corp's latest version of its injectable knee pain treatment may be inadequate to weigh how well the product works, U.S. regulatory reviewers said in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results